News
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.
The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...
Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.
The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.
The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...
The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting wearable on the market.
has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for individuals 18 years and older with diabetes. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results